HBV-miR-3 and cGAS-STING axis: a new frontier in hepatitis B therapy. [PDF]
Front Cell Infect MicrobiolHua C, Aftab S, Baloch Z.
europepmc +1 more source
The mechanism of action of interferon: a comparison of ribosomes from interferon-treated and control cells [PDF]
, 1969 Ian M. Kerr +3 more
openalex +1 more source
Advanced Science, EarlyView.This study identifies ARID1B as a chromatin‐bound driver of tumor growth in TNBC. ARID1B impairs ARID1A function and directly activates oncogenic programs through SWI/SNF remodeling. Its nuclear localization, mediated by the KPNA2–KPNB1–RANBP2 import machinery, is essential for its tumor‐promoting activity.
Olena Odnokoz +14 more
wiley +1 more source
Control of MAIT cell functions by cytokines in health and disease. [PDF]
Front ImmunolCamard L, Bianchi E, Rogge L.
europepmc +1 more source
INCREASED SURVIVAL IN MICE INOCULATED WITH TUMOR CELLS AND TREATED WITH INTERFERON PREPARATIONS [PDF]
, 1969 Ion Gresser +4 more
openalex +1 more source
Advanced Science, EarlyView.This study develops an a red/far‐red light‐controlled iPSC‐based vaccines (RIVA) based on the chimeric photosensory protein FnBphP and its interaction partner LDB3 for cancer immunotherapy. The RIVA preserves the multiple intrinsic tumor antigens of iPSCs and enables optogenetic control of the expression of the immune adjuvant type I interferon β under
Longliang Qiao +17 more
wiley +1 more source
Chasing Virus Replication and Infection: PAMP-PRR Interaction Drives Type I Interferon Production, Which in Turn Activates ISG Expression and ISGylation. [PDF]
VirusesMuhammad I, Contes K, Bility MT, Tang Q.
europepmc +1 more source
Technological Discontinuities and the Comparative Strategic Value of New Capabilites: Evidence from the Comparison of Small- and Large-Molecule Targeted Anti-Cancer Drug Discovery [PDF]
Traditional creative destruction theories distinguish disruptions as competence-destroying or competence-enhancing to incumbents’ capabilities, with the former case resulting in incumbents’ loss of competitive advantage in in-house R&D performance (even ...
M. Lourdes Sosa
core
Interferon and Resistance to the Toxic Effects of Influenza Virus in vivo
, 1969 A. A. Smorodintsev +4 more
openalex +1 more source
Microassay for Human and Chick Cell Interferon [PDF]
, 1968 Jeremiah G. Tilles, Maxwell Finland
openalex +1 more source